In the article titled “Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences” [1], with regard to the FRAX® tool, it has been reported that “Among the different tools to assess fracture risk, the WHO fracture risk assessment (FRAX) is a computer based algorithm (http://www.shef.ac.uk/FRAX/) primarily intended for use in primary care [56, 57].” We point out that the metabolic bone disease unit at the University of Sheffield that developed FRAX was a WHO Collaborating Centre from 1991 to 2010, but the World Health Organization (WHO) did not develop, test, or endorse the FRAX tool or its recommendations [2]. Additionally, the name of the fourth author was given incorrectly as Morabito Nunziata. The author's name should have been written as Nunziata Morabito. The revised authors' list is shown above.
References
- 1.Russo G. T., Giandalia A., Romeo E. L., et al. Fracture risk in type 2 diabetes: current perspectives and gender differences. International Journal of Endocrinology. 2016;2016:11. doi: 10.1155/2016/1615735.1615735 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Ford N., Norris S. L., Hill S. R. Clarifying WHO’s position on the FRAX® tool for fracture prediction. Bulletin of the World Health Organization. 2016;94(12):p. 862. doi: 10.2471/BLT.16.188532. [DOI] [PMC free article] [PubMed] [Google Scholar]
